1. Home
  2. MNKD vs HLMN Comparison

MNKD vs HLMN Comparison

Compare MNKD & HLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • HLMN
  • Stock Information
  • Founded
  • MNKD 1991
  • HLMN 1964
  • Country
  • MNKD United States
  • HLMN United States
  • Employees
  • MNKD N/A
  • HLMN N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • HLMN Industrial Machinery/Components
  • Sector
  • MNKD Health Care
  • HLMN Consumer Discretionary
  • Exchange
  • MNKD Nasdaq
  • HLMN Nasdaq
  • Market Cap
  • MNKD 1.7B
  • HLMN 1.9B
  • IPO Year
  • MNKD 2004
  • HLMN N/A
  • Fundamental
  • Price
  • MNKD $5.00
  • HLMN $8.27
  • Analyst Decision
  • MNKD Buy
  • HLMN Buy
  • Analyst Count
  • MNKD 6
  • HLMN 6
  • Target Price
  • MNKD $10.25
  • HLMN $12.20
  • AVG Volume (30 Days)
  • MNKD 4.3M
  • HLMN 949.4K
  • Earning Date
  • MNKD 11-05-2025
  • HLMN 11-04-2025
  • Dividend Yield
  • MNKD N/A
  • HLMN N/A
  • EPS Growth
  • MNKD 23.47
  • HLMN 388.43
  • EPS
  • MNKD 0.10
  • HLMN 0.19
  • Revenue
  • MNKD $313,787,000.00
  • HLMN $1,536,647,000.00
  • Revenue This Year
  • MNKD $14.78
  • HLMN $8.11
  • Revenue Next Year
  • MNKD $19.36
  • HLMN $7.85
  • P/E Ratio
  • MNKD $50.82
  • HLMN $43.51
  • Revenue Growth
  • MNKD 17.43
  • HLMN 4.47
  • 52 Week Low
  • MNKD $3.38
  • HLMN $6.55
  • 52 Week High
  • MNKD $7.07
  • HLMN $11.64
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 39.71
  • HLMN 26.26
  • Support Level
  • MNKD $4.95
  • HLMN $8.56
  • Resistance Level
  • MNKD $6.24
  • HLMN $8.93
  • Average True Range (ATR)
  • MNKD 0.29
  • HLMN 0.30
  • MACD
  • MNKD -0.08
  • HLMN -0.09
  • Stochastic Oscillator
  • MNKD 4.26
  • HLMN 1.38

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About HLMN Hillman Solutions Corp.

Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the company are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the U.S., Canada and Mexico.

Share on Social Networks: